Global supply chains are becoming increasingly complex, formulations more complicated and new manufacturing processes can be fraught with uncertainties. And these are just some of the factors that make it difficult for the pharmaceutical industry to identify, evaluate and control potential impurities in active ingredients, excipients and finished drug products in a timely manner. Even robust analytical method development requires impurities that can be relied upon for quality.
If you want to save valuable time and resources and reduce risks related to quality, you rely on USP's Pharmaceutical Analytical Impurities (PAI) early on, and thus on one of the best-known trusted sources. PAIs can be used for both qualitative and quantitative analyses.
In addition, this gives you peace of mind as you move from research and development to larger scale production and manufacturing.
Did you know... that over 400 PAIs (Pharmaceutical Analytical Impurities) are already available from USP? And interesting new ones are being added all the time! Increase your quality already in the early R&D phase and in the process development for production!
Use the time-saving PAI from USP now!
You can request the catalog of available PAI informally from us at: reference-standards@bpt.eurofinseu.com
PAI products differ from the official USP reference standards. PAI products are not required for compendial compliance, but are highly recommended.
